These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31609924)

  • 1. Insula Activity to Visceral Stimulation and Endocrine Stress Responses as Associated With Alexithymia in Patients With Irritable Bowel Syndrome.
    Kano M; Muratsubaki T; Yagihashi M; Morishita J; Mugikura S; Dupont P; Takase K; Kanazawa M; Van Oudenhove L; Fukudo S
    Psychosom Med; 2020 Jan; 82(1):29-38. PubMed ID: 31609924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Uncertain Anticipation on Brain Responses to Aversive Rectal Distension in Patients With Irritable Bowel Syndrome.
    Kano M; Muratsubaki T; Morishita J; Kono K; Mugikura S; Takase K; Ly HG; Dupont P; Van Oudenhove L; Fukudo S
    Psychosom Med; 2017; 79(9):988-999. PubMed ID: 28498276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.
    Kano M; Muratsubaki T; Van Oudenhove L; Morishita J; Yoshizawa M; Kohno K; Yagihashi M; Tanaka Y; Mugikura S; Dupont P; Ly HG; Takase K; Kanazawa M; Fukudo S
    Sci Rep; 2017 Sep; 7(1):12425. PubMed ID: 28963545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient habituation to repeated rectal distensions in irritable bowel syndrome patients with visceral hypersensitivity.
    Lowén MB; Mayer E; Tillisch K; Labus J; Naliboff B; Lundberg P; Thorell LH; Ström M; Engström M; Walter S
    Neurogastroenterol Motil; 2015 May; 27(5):646-55. PubMed ID: 25777251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between sympathoadrenal and pituitary-adrenal response during colorectal distention in the presence of corticotropin-releasing hormone in patients with irritable bowel syndrome and healthy controls.
    Tanaka Y; Kanazawa M; Kano M; Tashiro M; Fukudo S
    PLoS One; 2018; 13(7):e0199698. PubMed ID: 29979696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls.
    Song GH; Venkatraman V; Ho KY; Chee MW; Yeoh KG; Wilder-Smith CH
    Pain; 2006 Dec; 126(1-3):79-90. PubMed ID: 16846694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parasympathetic activity correlates with subjective and brain responses to rectal distension in healthy subjects but not in non-constipated patients with irritable bowel syndrome.
    Kano M; Yoshizawa M; Kono K; Muratsubaki T; Morishita J; Van Oudenhove L; Yagihashi M; Mugikura S; Dupont P; Takase K; Kanazawa M; Fukudo S
    Sci Rep; 2019 May; 9(1):7358. PubMed ID: 31089154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Activation in Amygdala and Plasma Noradrenaline during Colorectal Distention by Administration of Corticotropin-Releasing Hormone between Healthy Individuals and Patients with Irritable Bowel Syndrome.
    Tanaka Y; Kanazawa M; Kano M; Morishita J; Hamaguchi T; Van Oudenhove L; Ly HG; Dupont P; Tack J; Yamaguchi T; Yanai K; Tashiro M; Fukudo S
    PLoS One; 2016; 11(7):e0157347. PubMed ID: 27448273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome.
    Berman SM; Naliboff BD; Suyenobu B; Labus JS; Stains J; Ohning G; Kilpatrick L; Bueller JA; Ruby K; Jarcho J; Mayer EA
    J Neurosci; 2008 Jan; 28(2):349-59. PubMed ID: 18184777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study.
    Elsenbruch S; Rosenberger C; Enck P; Forsting M; Schedlowski M; Gizewski ER
    Gut; 2010 Apr; 59(4):489-95. PubMed ID: 19651629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response.
    Park SH; Naliboff BD; Shih W; Presson AP; Videlock EJ; Ju T; Kilpatrick L; Gupta A; Mayer EA; Chang L
    Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 28718999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
    Fukudo S
    J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excessive coupling of the salience network with intrinsic neurocognitive brain networks during rectal distension in adolescents with irritable bowel syndrome: a preliminary report.
    Liu X; Silverman A; Kern M; Ward BD; Li SJ; Shaker R; Sood MR
    Neurogastroenterol Motil; 2016 Jan; 28(1):43-53. PubMed ID: 26467966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal forebrain activity in functional bowel disorder patients with chronic pain.
    Kwan CL; Diamant NE; Pope G; Mikula K; Mikulis DJ; Davis KD
    Neurology; 2005 Oct; 65(8):1268-77. PubMed ID: 16247056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress.
    Posserud I; Agerforz P; Ekman R; Björnsson ES; Abrahamsson H; Simrén M
    Gut; 2004 Aug; 53(8):1102-8. PubMed ID: 15247175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered brain responses in subjects with irritable bowel syndrome during cued and uncued pain expectation.
    Hong JY; Naliboff B; Labus JS; Gupta A; Kilpatrick LA; Ashe-McNalley C; Stains J; Heendeniya N; Smith SR; Tillisch K; Mayer EA
    Neurogastroenterol Motil; 2016 Jan; 28(1):127-38. PubMed ID: 26526698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain activation responses to subliminal or supraliminal rectal stimuli and to auditory stimuli in irritable bowel syndrome.
    Andresen V; Bach DR; Poellinger A; Tsrouya C; Stroh A; Foerschler A; Georgiewa P; Zimmer C; Mönnikes H
    Neurogastroenterol Motil; 2005 Dec; 17(6):827-37. PubMed ID: 16336498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.
    Labus JS; Hubbard CS; Bueller J; Ebrat B; Tillisch K; Chen M; Stains J; Dukes GE; Kelleher DL; Naliboff BD; Fanselow M; Mayer EA
    Gastroenterology; 2013 Dec; 145(6):1253-61.e1-3. PubMed ID: 23954313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Cerebellar Activity in Visceral Pain-Related Fear Conditioning in Irritable Bowel Syndrome.
    Claassen J; Labrenz F; Ernst TM; Icenhour A; Langhorst J; Forsting M; Timmann D; Elsenbruch S
    Cerebellum; 2017 Apr; 16(2):508-517. PubMed ID: 27797090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.
    Sagami Y; Shimada Y; Tayama J; Nomura T; Satake M; Endo Y; Shoji T; Karahashi K; Hongo M; Fukudo S
    Gut; 2004 Jul; 53(7):958-64. PubMed ID: 15194643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.